MedTrace Logo

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in ShangHai

NCT03533543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2399

Last updated 2024-07-16

No results posted yet for this study

Summary

To characterize and estimate the incidence rate of new-onset atrial fibrillation (NOAF) in patients with acute myocardial infarction (MI). To explore the prognostic influences of NOAF on MI patients' clinical outcomes. To further investigate the impact of NOAF associated characteristics on patients' clinical outcomes eithier during hospitalization or follow-up period.

Conditions

Interventions

DEVICE

CEM

All patients with MI hospitalized in the CCU department of Shanghai Tenth People's Hospital will receive 24-hour cardiac monitoring until discharge.

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yidong Wei, MD, PhD · Department of Cardiology, Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-20
Primary Completion
2019-06-01
Completion
2019-09-13

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03533543 on ClinicalTrials.gov